Benjamin Hickey

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Benjamin Hickey
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin Hickey:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BRISTOL MYERS SQUIBB CO President, RayzeBio Org. Market Share Units 13.4K $709K $52.99 10 Mar 2025 Direct
BRISTOL MYERS SQUIBB CO President, RayzeBio Org. Common Stock, $0.10 par value 8.79K $472K $53.74 09 May 2025 Direct
BRISTOL MYERS SQUIBB CO President, RayzeBio Org. Restricted Stock Units 6.57K $348K $52.99 01 Mar 2025 Direct
Mural Oncology plc Director Stock Option (right to buy) 0 $28.3K $3.35 05 Dec 2025 Direct
BRISTOL MYERS SQUIBB CO President, RayzeBio Org. Common Stock, $0.10 par value 0 $0 $38.01 09 May 2025 By Spouse
Surface Oncology, Inc. Director Stock Option (Right to Buy) 24K 08 Jun 2022 Direct
BRISTOL MYERS SQUIBB CO President, RayzeBio Org. Performance Shares 20.1K 10 Mar 2025 Direct
Mirati Therapeutics, Inc. EVP, Chief Commercial Officer Common Stock 0 $59.02 23 Jan 2024 Direct
Mirati Therapeutics, Inc. EVP, Chief Commercial Officer Option to Purchase Common Stock 0 23 Jan 2024 Direct

Insider Reports Filed by Benjamin Hickey

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MURA Mural Oncology plc 05 Dec 2025 3 $0 4 Director 05 Dec 2025, 09:16
MURA Mural Oncology plc 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 08:00
BMY BRISTOL MYERS SQUIBB CO 09 May 2025 1 -$3.7K 4 President, RayzeBio Org. 13 May 2025, 19:03
BMY BRISTOL MYERS SQUIBB CO 10 Mar 2025 2 $0 4 President, RayzeBio Org. 12 Mar 2025, 21:29
BMY BRISTOL MYERS SQUIBB CO 01 Mar 2025 3 -$97.2K 4 President, RayzeBio Org. 04 Mar 2025, 17:44
BMY BRISTOL MYERS SQUIBB CO 01 Feb 2025 3 -$220K 4 President, RayzeBio Org. 04 Feb 2025, 19:05
MURA Mural Oncology plc 30 May 2024 1 $0 4/A Director 05 Jun 2024, 16:16
MURA Mural Oncology plc 30 May 2024 1 $28.3K 4 Director 03 Jun 2024, 10:23
BMY BRISTOL MYERS SQUIBB CO 10 Mar 2024 2 $0 4 President, RayzeBio Org. 12 Mar 2024, 17:45
BMY BRISTOL MYERS SQUIBB CO 01 Mar 2024 1 $0 4 President, RayzeBio Org. 04 Mar 2024, 17:57
BMY BRISTOL MYERS SQUIBB CO 26 Feb 2024 0 $0 3 President, RayzeBio Org. 04 Mar 2024, 17:52
MRTX Mirati Therapeutics, Inc. 23 Jan 2024 5 $0 4 EVP, Chief Commercial Officer 23 Jan 2024, 20:37
MRTX Mirati Therapeutics, Inc. 16 Jan 2024 2 -$94.3K 4 EVP, Chief Commercial Officer 18 Jan 2024, 16:45
MRTX Mirati Therapeutics, Inc. 08 Jan 2024 1 -$123K 4 EVP, Chief Commercial Officer 09 Jan 2024, 17:54
MRTX Mirati Therapeutics, Inc. 29 Dec 2023 1 $1M 4 EVP, Chief Commercial Officer 03 Jan 2024, 18:13
MURA Mural Oncology plc 14 Dec 2023 1 $0 4 Director 18 Dec 2023, 16:30
MRTX Mirati Therapeutics, Inc. 13 Dec 2023 1 -$126K 4 EVP, Chief Commercial Officer 14 Dec 2023, 17:05
MURA Mural Oncology plc 31 Oct 2023 0 $0 3 Director 07 Nov 2023, 16:24
MRTX Mirati Therapeutics, Inc. 09 Aug 2023 1 $825K 4 EVP, Chief Commercial Officer 10 Aug 2023, 16:23
MRTX Mirati Therapeutics, Inc. 20 Jan 2023 2 $0 4 EVP, Chief Commercial Officer 24 Jan 2023, 15:00
MRTX Mirati Therapeutics, Inc. 17 Jan 2023 2 -$66.4K 4 EVP, Chief Commercial Officer 19 Jan 2023, 08:45
MRTX Mirati Therapeutics, Inc. 09 Jan 2023 1 -$94.7K 4 EVP, Chief Commercial Officer 10 Jan 2023, 16:00
MRTX Mirati Therapeutics, Inc. 19 Dec 2022 2 -$131K 4 EVP, Chief Commercial Officer 21 Dec 2022, 20:20
SURF Surface Oncology, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 20:00
MRTX Mirati Therapeutics, Inc. 14 Jan 2022 3 -$75.5K 4 EVP, Chief Commercial Officer 18 Jan 2022, 19:32
MRTX Mirati Therapeutics, Inc. 07 Jan 2022 1 -$267K 4 EVP, Chief Commercial Officer 07 Jan 2022, 19:27
SURF Surface Oncology, Inc. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 17:00
SURF Surface Oncology, Inc. 09 Dec 2021 0 $0 3 Director 16 Dec 2021, 15:23